Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

High Risk

Score: 60/100

Failure Rate

14.3%

1 terminated/withdrawn out of 7 trials

Success Rate

83.3%

-3.2% vs industry average

Late-Stage Pipeline

0 trials in Phase 3/4

Results Transparency

0 of 5 completed trials have results

Key Signals

Enrollment Performance

Analytics

Early Phase 1

1(50.0%)

Phase 2

1(50.0%)

2Total

Early Phase 1(1)

Phase 2(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (7)

Showing 7 of 7 trials

NCT01099800Completed

Asthma Disparities in Latino Children:Acculturation,Illness Representations & CAM

Role: collaborator

NCT01443390Completed

An Ancillary Pilot Trial Using Whole Genome Sequencing In Patients With Advance Refractory Cancer

Role: lead

NCT00597740Completed

Propofol Sedation Study

Role: lead

NCT01476982Unknown

Evaluation of Patients in Chest Pain in the Emergency Room

Role: collaborator

NCT01196247Phase 2Completed

A Study of Therapy Selected by Molecular/Metabolic Profiling in Patients With Previously Treated Metastatic Pancreatic Cancer

Role: collaborator

NCT00530192Early Phase 1Completed

Molecular Profiling Protocol (SCRI-CA-001)

Role: lead

NCT00607425Terminated

Saliva mRNA Expression Profiling for Early Stage Non-Small Cell Lung Cancer Screening

Role: lead

All 7 trials loaded